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Francisella tularensis replicates in macrophages and dendritic cells, but interactions with other cell types
have not been well described. F. tularensis LVS invaded and replicated within alveolar epithelial cell lines.
Following intranasal inoculation of C57BL/6 mice, Francisella localized to the alveolus and replicated within
alveolar type II epithelial cells.
Francisella tularensis, the etiological agent of tularemia, is a
zoonotic pathogen with a broad host range, spanning from
protists to humans. The organism is transmitted to humans
through handling of contaminated material, insect bites, or
inhalation (6, 10). It has been determined that contact with 25
or fewer bacteria is sufficient to cause disease (16, 17). Follow-
ing contact, the bacteria disseminate to the liver, spleen, and
lungs regardless of the initial transmission route (7, 10).
The low infectious dose, myriad of transmission routes,
broad host range, and severity of disease caused by F. tularensis
led a number of nations to develop and stockpile this organism
as a biological weapon (9), yet little is known about the basis of
its pathogenesis or virulence. It has been reported that mac-
rophages and, potentially, dendritic cells serve as the primary
host cells for growth of Francisella in humans and other ani-
mals (5, 18). This conclusion is supported by the observations
that F. tularensis and other closely related Francisella species
survive and replicate in human and rodent macrophages (1, 4)
and that many of the identified attenuating mutations impair
intramacrophage growth (2, 11, 12, 14, 15).
Clearly, intramacrophage survival is an important virulence
property of Francisella. However, apart from one report of
hepatocyte association in infected liver (8), the potential con-
tribution of other host cell interactions to F. tularensis viru-
lence and pathogenesis remains untested. Given the severity of
tularemia acquired by inhalation, we sought to address this
possibility by using in vitro and in vivo models to examine
whether Francisella invades and replicates within epithelial
cells of the lung.
Francisella tularensis LVS invades and replicates within lung
epithelial cells in vitro. To determine whether Francisella
could invade and replicate within lung epithelial cells, in vitro
invasion and replication assays were performed using the hu-
man alveolar type II (ATII) epithelial cell-derived cell line
A549 (ATCC), the mouse ATII cell-derived cell line MLE-12
(ATCC), and the mouse lung epithelial cell-derived cell line
Tc-1 (ATCC). For comparison, the mouse macrophage-like
cell line J774A.1 (ATCC) was also used. Intracellular bacteria
were enumerated by a gentamicin protection assay. The cell
lines were grown to confluence in 24-well plates and inoculated
with F. tularensis LVS at a multiplicity of infection of 100:1.
Four hours after inoculation, the cells were washed with phos-
phate-buffered saline (PBS), and medium containing gentami-
cin (25 g/ml) was added to kill extracellular bacteria.
Intracellular organisms were recovered from all cell lines 6
and 24 h postinoculation (Fig. 1A). The number of intracellu-
lar organisms recovered 6 h postinoculation and the percent-
age of infected cells varied among the lung epithelial cell lines,
with the fewest intracellular Francisella organisms recovered
from the human ATII cell line, A549. The percentage of in-
fected epithelial cells ranged from 0.2% of A549 cells to 17%
of Tc-1 cells (Fig. 1A). The number of intracellular bacteria
recovered from each lung epithelial cell line at 6 h was smaller
than the number recovered from J774A.1 cells, as was the
percentage of infected cells, indicating that entry into epithe-
lial cells may be a less efficient process than uptake by macro-
phages.
The number of intracellular bacteria increased by an average
of 100-fold during the following 18 h in each cell line, repre-
senting an intracellular doubling time of roughly 3 h (Fig. 1A).
Intracellular localization and proliferation were confirmed us-
ing fluorescence microscopy and digital image deconvolution
(Fig. 1B to E). From 6 to 24 h postinoculation, the relative
increase of intracellular bacteria within lung epithelial cells was
similar to that observed within J774A.1 cells, indicating that F.
tularensis LVS replicated to the same degree within lung epi-
thelial cells as in macrophages.
There are many reports of Francisella replicating within
macrophages in vitro, and here we report its ability to replicate
within cultured lung epithelial cells. Whereas some work has
been done to examine localization of Francisella in the liver
(8), little is known about the localization of inhaled Francisella
in the lung. Bosio and Dow recently reported that Francisella
was associated primarily with dendritic cells isolated from
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FIG. 1. F. tularensis LVS invades and replicates within ATII cell lines in vitro. (A) Intracellular bacteria recovered from A549, MLE-12, Tc-1, and
J774A.1 cells 6 and 24 h postinoculation. The percentages above the bars represent percentages of infected cells. (B and C) Fluorescence imaging of A549
cells inoculated with GFP-expressing LVS 6 h (B) and 24 h (C) following inoculation. Cell borders were visualized by rhodamine-phalloidin (Molecular
Probes) staining (red), and nuclei were visualized with 4,6-diamidino-2-phenylindole (DAPI; blue). (D and E) Fluorescence imaging of J774A.1 cells
inoculated with GFP-expressing LVS (green) 6 h (D) and 24 h (E) postinoculation. Cell borders were visualized using biotinylated lectin from Lens
culinaris and streptavidin-conjugated Alexa Fluor 647 (Molecular Probes) (red), and nuclei were stained with DAPI (blue). Intracellular replication
experiments were carried out in triplicate; error bars represent standard deviations of the means.
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bronchioalveolar lavage fluid of mice 1 hour after inhalation
(5). However, the localization of bacteria in lung tissue
throughout the course of infection has not been addressed.
Following inhalation, Francisella localizes to the alveolus.
To determine the localization of Francisella in the airway
following inhalation, anesthetized 6- to 8-week-old female
C57BL/6 mice were inoculated intranasally with 105 CFU of
F. tularensis LVS expressing green fluorescent protein
(GFP) suspended in 50 l of PBS. (All mouse work was
performed according to IACUC-approved protocol.) Immu-
nofluorescence analysis was performed on formalin-fixed
and paraffin-embedded tissue sections obtained from nasal
turbinates, trachea, and lungs harvested 1, 3, and 7 days
postinoculation. No bacteria were observed in turbinates or
trachea. In the lung, few bacteria associated with the apical
surface of bronchial epithelial cells, while the majority
colocalized with alveolar cells (Fig. 2). Fluorescence imaging
of sequential vertical planes revealed that most infected alve-
olar cells contained multiple bacteria throughout the cyto-
plasm, indicative of intracellular replication (data not shown).
Bacterial replication within ciliated or nonciliated (Clara)
bronchial epithelial cells was not observed. The absolute num-
ber of bacteria (Fig. 2D) and the number of infected alveolar
cells increased by day 3 (Fig. 2B). By day 7, F. tularensis within
the lung was widespread but remained exclusively in the alve-
olus (Fig. 2C). Throughout the course of infection, the amount
of extracellular space observed in the network of alveolar cells
decreased, causing the alveolar cells to appear more con-
densed (Fig. 2).
Inhaled Francisella colocalizes to and replicates within ATII
cells in vivo. Given that Francisella invaded and replicated
within ATII-derived cell lines in vitro, we probed infected
lung tissue sections with antibodies to the nonsecreted sur-
factant protein precursors proSP-B and proSB-C (Chemi-
con) to determine whether Francisella localized to and rep-
licated within ATII cells in vivo following inhalation.
proSP-B is produced by ATII cells and nonciliated bron-
chiolar Clara cells (13), whereas proSP-C is produced by
ATII cells exclusively (3). Three days following inoculation,
the majority of alveolar cells associated with F. tularensis
also bound antibodies to the nonsecreted surfactant protein
precursors proSP-B and proSB-C (Fig. 3A to D). Some cells
associated with bacteria were not positive for proSP-B or
FIG. 2. F. tularensis localizes to the alveolus following inhalation. Mice were intranasally inoculated with 105 CFU of F. tularensis LVS
expressing GFP. One, three, and seven days postinoculation, lungs were harvested and prepared for immunofluorescence analysis. (A to C)
Bacterial localization was determined by probing lung sections with a fluorescently labeled antibody to GFP (green). Nuclei were stained with
DAPI (blue) to visualize lung cells. Representative images of the alveoli of infected mice 1 (A), 3 (B), and 7 (C) days postinoculation. (D) Bacterial
recovery from lungs 1, 3, and 7 days following intranasal inoculation with 105 CFU LVS. Each bar represents mean recovery from three mice; error
bars represent standard deviations of the means.
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proSP-C, indicating that Francisella interacts with other cell
types in the lung following inhalation.
In addition to the colocalization with proSP proteins, mi-
croscopy of sequential vertical planes confirmed that bacteria
were inside infected ATII cells (data not shown). Rabbit anti-
body specific for -tubulin (Abcam) did not colocalize with F.
tularensis (Fig. 3E), indicating that the colocalization of Fran-
cisella with rabbit proSP antibodies was not due to bacteria
FIG. 3. Following inhalation, F. tularensis LVS expressing GFP colocalized with proSP-B and proSP-C, proteins produced by ATII epithelial
cells. Bacterial localization was determined with a fluorescently labeled antibody to GFP (green). Nuclei were stained with DAPI (blue). Sections
were probed with fluorescently labeled antibody to proSP-B (red) (A and B), proSP-C (red) (C and D) to identify ATII cells and -tubulin (red)
(E). Representative images are from lung sections 3 days postinoculation.
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nonspecifically binding rabbit antibodies, nor did the proSP
antibodies cross-react with cultured Francisella organisms
(data not shown). These collective data demonstrate that F.
tularensis replicates within ATII cells following inhalation and
the proportion of ATII cells harboring bacteria increases dur-
ing the course of pneumonic tularemia.
Bacteria were also observed in probed sections that did not
colocalize with proSP-B and proSP-C (Fig. 3), indicating that
ATII cells are not the only alveolar cell type harboring repli-
cating Francisella. Macrophages and dendritic cells have been
reported as potential host cells for replicating Francisella or-
ganisms (1, 4, 5). Due to difficulties in staining for surface
macrophage and dendritic cell markers in embedded lung sec-
tions, we utilized dispase digestion of infected mouse lungs to
stain for surface markers and also to assess our results from the
embedded tissue staining.
Three days after inoculation with LVS expressing GFP,
lungs were infused and incubated with the neutral protease
dispase (BD Biosciences). Digested tissue was washed in PBS
and subsequently filtered through 40- and 20-m-pore-size
mesh. Staining with fluorescently labeled antibody specific for
the surface markers F4/80 (eBioscience) and CD11c (eBio-
science) was performed prior to fixation with 4% paraformal-
dehyde. Staining for the intracellular markers proSP-B and
proSP-C occurred following fixation and required the use of
Cytoperm (BD Biosciences) to permeabilize the cells. F. tula-
rensis LVS was observed within cells expressing F4/80, CD11c,
proSP-B, and proSP-C (Fig. 4), indicating that following inha-
lation, bacteria survive and replicate within macrophages,
dendritic cells, and ATII cells.
Here we report that in addition to replicating within mac-
rophages and dendritic cells, F. tularensis invades and rep-
licates within alveolar type II epithelial cells, indicating that
interaction with these cells following inhalation may be an
important component of pneumonic tularemia. Future work
will analyze the proportion of various cell types that are
infected in the lung as well as attempt to identify the con-
tribution of ATII cell invasion and replication to the disease
progression of pneumonic tularemia.
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